APA (7th ed.) Citation

N, S., R, Y., YM, G., H, N., S, C., K, M., . . . J, Y. (2026). Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study. Cureus, 18(3), e105578. https://doi.org/10.7759/cureus.105578

Chicago Style (17th ed.) Citation

N, Sato, Yoshimaru R, Guo YM, Nakamura H, Chi S, Matsuda K, Minami Y, and Yuda J. "Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study." Cureus 18, no. 3 (2026): e105578. https://doi.org/10.7759/cureus.105578.

MLA (9th ed.) Citation

N, Sato, et al. "Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study." Cureus, vol. 18, no. 3, 2026, p. e105578, https://doi.org/10.7759/cureus.105578.